Bristol-Myers Squibb Acquires Mirati Therapeutics
Bristol-Myers Squibb acquired Mirati Therapeutics for $4.8B. View deal terms, timeline, and press on Fsome.
Deal Details
- Acquirer
- Bristol-Myers Squibb
- Acquired Company
- Mirati Therapeutics
- Price
- $4.8B
- Acquisition Type
- Acquisition
- Announced
- October 8, 2023
Canonical: https://fsome.com/acquisitions/bristol-myers-squibb-acquires-mirati-therapeutics-8197767 · For the full deal terms, timeline, and press references, please enable JavaScript.